A detailed comparison of Leukeran (chlorambucil) with newer chemotherapy and targeted agents for chronic lymphocytic leukemia and non‑Hodgkin lymphoma, covering efficacy, safety, and practical use.
A detailed comparison of Leukeran (chlorambucil) with newer chemotherapy and targeted agents for chronic lymphocytic leukemia and non‑Hodgkin lymphoma, covering efficacy, safety, and practical use.